Literature DB >> 12212582

A case of extramedullary plasmacytoma of the larynx.

Takahiro Kamijo1, Katsuhide Inagi, Masami Nakajima, Tadashi Motoori, Katsumi Tadokoro, Shougo Nishiyama.   

Abstract

An 84-year-old male with a complaint of hoarseness was examined. A mass lesion was recognized in the false vocal fold. The tumor was excised and found to consist of atypical plasmacytes. Immunopathological examination revealed that leukocyte common antigen (CD45), UCHLI (CD45RO), CD3 and L26 (CD20) were negative and that CD79 and Vs38C were positive. Neither uric Bence-Jones protein nor serum M-protein were observed. No other bony abnormalities were recognized on X-ray examinations including both bone and Ga scintigraphy. No atypical plasmacyte infiltration was observed in bone marrow. Our final diagnosis was extramedullary plasmacytoma of the larynx. Radiotherapy was performed following surgery. The tumor did not progress to multiple myeloma and no recurrence has been observed after 2 years.

Entities:  

Mesh:

Year:  2002        PMID: 12212582     DOI: 10.1080/000164802760057707

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  3 in total

Review 1.  Prognostic factors of laryngeal solitary extramedullary plasmacytoma: a case report and review of literature.

Authors:  Yong Xing; Jun Qiu; Min-Li Zhou; Shui-Hong Zhou; Yang-Yang Bao; Qin-Ying Wang; Zhou-Jun Zheng
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  Extramedullary plasmacytoma of the larynx: Literature review and report of a case who subsequently developed acute myeloid leukemia.

Authors:  Shenglei Ge; Ganghua Zhu; Yan Yi
Journal:  Oncol Lett       Date:  2018-06-19       Impact factor: 2.967

3.  Solitary Extramedullary Plasmacytoma of the Larynx and Secondary Laryngeal Involvement in Plasma Cell Myeloma: Single-Centre Retrospective Analysis and Systematic Literature Review.

Authors:  Elżbieta Szczepanek; Joanna Drozd-Sokołowska; Jacek Sokołowski; Anna Rzepakowska; Arkadiusz Moskwa; Jakub Pachla; Jakub Grzybowski; Katarzyna Woźnica; Kazimierz Niemczyk; Krzysztof Jamroziak
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.